Sei Investments CO Precigen, Inc. Transaction History

Sei Investments CO

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.88 - $2.19 $200,509 - $498,995	227,852 Added 27.88%	1,045,167 $1.11 Million
Q4 2022 Feb 10, 2023	SELL	$1.27 - $2.26 $20,320 - $36,160	-16,000 Reduced 1.92%	817,315 $1.24 Million
Q3 2022 Nov 14, 2022	BUY	$1.41 - $2.79 $22,560 - $44,640	16,000 Added 1.96%	833,315 $1.77 Million
Q1 2022 May 13, 2022	BUY	$1.91 - $3.98 $87,481 - $182,291	45,802 Added 5.94%	817,315 $1.73 Million
Q4 2021 Feb 14, 2022	BUY	$3.53 - $5.5 $1.35 Million - $2.1 Million	382,625 Added 98.39%	771,513 $2.86 Million
Q1 2021 May 12, 2021	BUY	$6.74 - $10.95 $2.62 Million - $4.26 Million	388,888 New	388,888 $2.68 Million

140

161M

232K

69K

Ticker PGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 208,150,000
Market Cap $281M
Description
Precigen, Inc. discovers and develops the next generation of gene and cellular therapies in the United States. It also provides disease-modifying therapeutics; genetically engineered swine for regenerative medicine applications; and reproductive and embryo transfer technologies. In addition, the company offers UltraVector platform that incorpora...

Get notified when there are updates to the investment portfolio of Sei Investments CO, based on Form 13F filings with the SEC.

Stay updated on Sei Investments CO with notifications on news.